Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer
Enteropathy-Associated T-Cell Lymphoma
Dren Biomonoclonal_antibodyPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
20 Active assets in the Enteropathy-Associated T-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Eric Jacobsen, MD | Phase 4 | BBB |
ETOPOSIDE Eric Jacobsen, MD | Phase 4 | BBB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 4 | BBB |
PREDNISONE TABLETS Eric Jacobsen, MD | Phase 4 | BB |
Ifosfamide Shandong Provincial Hospital | Phase 4 | BB |
View all 36 →
Same molecule, other indications
Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer is also rated in:
primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →